Risk adjusted net present value: What is the current valuation of Pfizer’s PF-07275315?

PF-07275315 is a monoclonal antibody commercialized by Pfizer, with a leading Phase II program in Atopic Dermatitis (Atopic Eczema).

California Child May Have Bird Flu After Drinking Raw Milk

A possible case of H5N1 bird flu virus in a California child has been linked to raw milk consumption and is under investigation by state

December 12, 2024

Many polio survivors face lifelong late effects

Polio survivors facing the little-known late effects of the disease are being overlooked, writes Neena Bhandari.

October 23, 2024

First AKT Inhibitor Approved for Advanced Breast Cancer

The FDA approved the first-in-class AKT inhibitor capivasertib (Truqap), in combination with fulvestrant, for locally advanced/metastatic hormone receptor (HR)-positive/HER2-negative breast cancer and at least one

November 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.